A senior official in the Central Drugs Standard Control Organisation (CDSCO) said, “The subject expert committee that went through the data and protocol submitted for the trial was satisfied with the results and based on their opinion the DCGI permitted its trial in India.”
Posted from: this blog via Microsoft Flow.
No comments:
Post a Comment